The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 15, 2007
Filed:
Apr. 12, 2002
Neil Barnwell, Leichestershire, GB;
Annika Björe, Mölndal, SE;
Lal Cheema, Leicestershire, GB;
David Cladingboel, Leichestershire, GB;
Adam Herring, Leicestershire, GB;
Karin Lövqvist, Mölndal, SE;
Neil Barnwell, Leichestershire, GB;
Annika Björe, Mölndal, SE;
Lal Cheema, Leicestershire, GB;
David Cladingboel, Leichestershire, GB;
Adam Herring, Leicestershire, GB;
Karin Lövqvist, Mölndal, SE;
Astrazeneca AB, Sodertalje, SE;
Abstract
There is provided substantially crystalline forms of 4-({3-[7-(3,3-dimethyl-2-oxobutyl) -9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl}amino)benzo-nitrile; tert-butyl 2 -{7-[3-(4-cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate; tert-butyl 2-{7-[4-(4-cyanophenyl)butyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethylcarbamate; or tert-butyl 2-{7-[2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo-[3.3.1]non-3-yl}ethylcarbamate and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of cardiac arhythmias.